Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAPID PRP Haematogel plus usual care vs usual care for chronic diabetic foot ulcers
2018-003596-36Phase 2Unknown
- Sponsor
- Biotherapy Services Limited
- Start
- Jun 2019
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of Angel PRP gel in diabetic foot ulcer (DFU) and type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Biotherapy Services Limited. Primary endpoint: Proportion of wounds healed at 12 weeks. Status: unknown.
02
Drugs
Angel PRP gel
03
Conditions
diabetic foot ulcer (DFU)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2018-003596-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-003596-36.